M&A, Partnering

Baring Asia acquires Bushu Pharmaceuticals

Posted on 18 November 2014

Tags: ,

Baring Private Equity Asia said on Monday it has agreed to buy Japanese drugmaker Bushu Pharmaceuticals, valued at 77.3 billion yen ($668 million), from Tokio Marine Capital.

Bushu is a leading pharmaceutical contract manufacturing organisation (CMO) in Japan.

For further deal information visit Current Agreements (subscription required)


Report:   Top 50 Big Pharma Partnering and M&A Deal Trends

Report:   Top 50 Big Biotech Partnering and M&A Deal Trends

Browse: Complete Current Partnering report catalog

Print Friendly, PDF & Email

Leave a Reply